AU7467094A - Method of diagnosing alzheimer's disease - Google Patents

Method of diagnosing alzheimer's disease

Info

Publication number
AU7467094A
AU7467094A AU74670/94A AU7467094A AU7467094A AU 7467094 A AU7467094 A AU 7467094A AU 74670/94 A AU74670/94 A AU 74670/94A AU 7467094 A AU7467094 A AU 7467094A AU 7467094 A AU7467094 A AU 7467094A
Authority
AU
Australia
Prior art keywords
disease
diagnosing alzheimer
alzheimer
diagnosing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74670/94A
Inventor
Hiroshi Marusawa
Kiminobu Sugaya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of AU7467094A publication Critical patent/AU7467094A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
AU74670/94A 1993-08-17 1994-08-17 Method of diagnosing alzheimer's disease Abandoned AU7467094A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP20344993 1993-08-17
JP5-203449 1993-08-17
PCT/JP1994/001359 WO1995005395A1 (en) 1993-08-17 1994-08-17 Method of diagnosing alzheimer's disease

Publications (1)

Publication Number Publication Date
AU7467094A true AU7467094A (en) 1995-03-14

Family

ID=16474309

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74670/94A Abandoned AU7467094A (en) 1993-08-17 1994-08-17 Method of diagnosing alzheimer's disease

Country Status (2)

Country Link
AU (1) AU7467094A (en)
WO (1) WO1995005395A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2234633A1 (en) * 1995-10-17 1997-04-24 G.D. Searle & Co. Method of detecting cyclooxygenase-2

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839283A (en) * 1986-12-30 1989-06-13 Zymogenetics, Inc. Method of expressing alpha-1-antitrypsin in yeast
JP2815461B2 (en) * 1990-05-09 1998-10-27 武田薬品工業株式会社 Neurotrophic activity inhibitor
US5473051A (en) * 1990-07-19 1995-12-05 The Scripps Research Institute Inhibition of Mac-1 receptor binding to fibrinogen using D30 homologs

Also Published As

Publication number Publication date
WO1995005395A1 (en) 1995-02-23

Similar Documents

Publication Publication Date Title
AU2414092A (en) Diagnostic method for alzheimer's disease
IL112050A0 (en) Methods of inhibiting alzheimer's disease
AU2765992A (en) Method for screening for alzheimer's disease
IL105216A0 (en) Method and kit for the diagnosis of alzheimer's disease
EP0773797A4 (en) A method of diagnosing alzheimer's disease
AU5508798A (en) Diagnostic and therapeutic reagents for alzheimer's disease
GB9316727D0 (en) Models of alzheimers's disease
AU8392291A (en) Tachykinin agonists for treatment of alzheimer's disease
AU1407399A (en) Treatment for alzheimer's disease
AU7556994A (en) Methods for the diagnosis of alzheimer's disease
AU7708498A (en) Nematode model for alzheimer's disease
AU5861096A (en) Process for making a doll's head looking like the head of a living person
AU7397094A (en) Prevention and treatment of alzheimer's disease
AU6268694A (en) Swimmer's aid
AU1189395A (en) Apolipoprotein e polymorphism and alzheimer's disease
AU5857296A (en) Use of leukotriene antagonists for alzheimer's disease
AU4636993A (en) Diagnosing alzheimer's disease and schizophrenia
AUPN649395A0 (en) A method for diagnosing alzheimer's disease
AU5053296A (en) Pharmaceutical agents for the treatment of Alzheimer's disease
AU1405899A (en) Treatment for alzheimer's disease
AU5880596A (en) Methods and compounds for diagnosing coronary artery disease
AU9017098A (en) Method for diagnosing alzheimer's disease
AU4012795A (en) Alzheimer's peptide
AU7201696A (en) Method of diagnosing crohn's disease
AU7467094A (en) Method of diagnosing alzheimer's disease